The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Substance use disorders in schizophrenia: review, integration, and a proposed model
Abstract
Substance use disorders occur in approximately 40 to 50% of individuals with schizophrenia. Clinically, substance use disorders are associated with a variety of negative outcomes in schizophrenia, including incarceration, homelessness, violence, and suicide. An understanding of the reasons for such high rates of substance use disorders may yield insights into the treatment of this comorbidity in schizophrenia. This review summarizes methodological and conceptual issues concerning the study of substance use disorders in schizophrenia and provides a review of the prevalence of this co-occurrence. Prevailing theories regarding the co-occurrence of schizophrenia and substance use disorders are reviewed. Little empirical support is found for models suggesting that schizophrenic symptoms lead to substance use (self-medication), that substance use leads to schizophrenia, or that there is a genetic relationship between schizophrenia and substance use. An integrative affect-regulation model incorporating individual differences in traits and responses to stress is proposed for future study.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In their model, Blanchard et al. (30) suggest that individuals with certain personality traits (i.e., negative affectivity/neuroticism and disinhibition/impulsivity) who also show difficulties in applying effective coping methods (e.g., interpersonal problem-solving) are more at risk of using substances to cope with negative emotion when encountering important stresses.”
From Mobile intervention for individuals with psychosis, dual disorders, and their common comorbidities: A literature review (2019) · cites this paper as [30]
Citations
Cites
Assessing coping strategies: A theoretically based approach.
Carver, C. S., Scheier, M. F., & Weintraub, J. K. (1989) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.56.2.267 · Cited by 11,507
Folkman, S., & Lazarus, R. S. (1985) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.48.1.150 · Cited by 4,845
Negative affectivity: the disposition to experience aversive emotional states
Watson, D., & Clark, L. A. (1984) · Psychological Bulletin · doi:10.1037/0033-2909.96.3.465 · Cited by 4,636
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications
Khantzian, E. J. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709030550 · Cited by 3,242
The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.11.1259 · Cited by 2,538
Problem solving and behavior modification.
D'Zurilla, T. J., & Goldfried, M. R. (1971) · Journal of Abnormal Psychology · doi:10.1037/h0031360 · Cited by 2,257
Neurogenetic Adaptive Mechanisms in Alcoholism
Cloninger, C. R. (1987) · Science · doi:10.1126/science.2882604 · Cited by 2,203
Drinking to regulate positive and negative emotions: A motivational model of alcohol use
Cooper, M. L., Frone, M. R., Russell, M., & Mudar, P. (1995) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.69.5.990 · Cited by 1,975
Vulnerability: A new view of schizophrenia.
Zubin, J., & Spring, B. J. (1977) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.86.2.103 · Cited by 1,941
Cited by
Sorted by citations
Chassin, L., Pitts, S. C., & Prost, J. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.70.1.67 · Cited by 766
Barrowclough, C., Haddock, G., Tarrier, N., Lewis, S. W., Moring, J., O’Brien, R., Schofield, N., & McGovern, J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1706 · Cited by 535
The social and economic burden of treatment-resistant schizophrenia: a systematic literature review
Kennedy, J. L., Altar, C. A., Taylor, D. L., Degtiar, I., & Hornberger, J. C. (2014) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32836508e6 · Cited by 392
Lambert, M., Conus, P., Lubman, D., Wade, D., Yuen, H. P., Moritz, S., Naber, D., McGorry, P., & Schimmelmann, B. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00554.x · Cited by 349
Affective traits in schizophrenia and schizotypy
Horan, W. P., Blanchard, J. J., Clark, L. A., & Green, M. F. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn083 · Cited by 290
Self-citationComorbid substance use and age at onset of schizophrenia
Barnes, T. R. E., Mutsatsa, S. H., Hutton, S. B., Watt, H., & Joyce, E. M. (2006) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.104.007237 · Cited by 271
Testing hypotheses about the relationship between cannabis use and psychosis
Degenhardt, L. J., Hall, W., & Lynskey, M. T. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00064-4 · Cited by 270
Reasons for increased substance use in psychosis
Gregg, L., Barrowclough, C., & Haddock, G. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.09.004 · Cited by 249
Emotion Regulation and Substance Use: A Meta-Analysis
Weiss, N. H., Kiefer, R., Goncharenko, S., Raudales, A. M., Forkus, S. R., Schick, M. R., & Contractor, A. A. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109131 · Cited by 235
Use of drugs, alcohol and tobacco by people with schizophrenia: case–control study
McCreadie, R. G. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.181.4.321 · Cited by 227
Cannabis use and misuse prevalence among people with psychosis
Green, B., Young, R. M., & Kavanagh, D. J. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.187.4.306 · Cited by 216
Varenicline Treatment of Concurrent Alcohol and Nicotine Dependence in Schizophrenia
Meszaros, Z. S., Abdul-Malak, Y., Dimmock, J. A., Wang, D., Ajagbe, T. O., & Batki, S. L. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182870551 · Cited by 206
Risk factors for violence among patients with schizophrenia
Bo, S., Abu-Akel, A. M., Kongerslev, M., Haahr, U., & Simonsen, E. H. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.03.002 · Cited by 202
Degenhardt, L. J., & Hall, W. (2001) · Psychological Medicine · doi:10.1017/s0033291701003865 · Cited by 193
Health habits of patients with schizophrenia
Roick, C., Fritz-Wieacker, A., Matschinger, H., Heider, D., Schindler, J., Riedel-Heller, S. G., & Angermeyer, M. C. (2007) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-007-0164-5 · Cited by 180
Cannabis use and the risk of developing a psychotic disorder
Hall, W., & Degenhardt, L. J. (2008) · World Psychiatry · doi:10.1002/j.2051-5545.2008.tb00158.x · Cited by 187
Schizophrenia and Criminal Offending
Tengström, A., Hodgins, S., Grann, M., Långström, N., & Kullgren, G. (2004) · Criminal Justice and Behavior · doi:10.1177/0093854804265173 · Cited by 167
McDonell, M. G., Short, R., Berry, C. M., & Dyck, D. G. (2003) · Family Process · doi:10.1111/j.1545-5300.2003.00091.x · Cited by 167
Mojtabai, R., Fochtmann, L. J., Chang, S.-W., Kotov, R., Craig, T., & Bromet, E. J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp045 · Cited by 167
Substance misuse in first-episode psychosis: 15-month prospective follow-up study
Wade, D., Harrigan, S., Edwards, J., Burgess, P., Whelan, G., & McGorry, P. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.017236 · Cited by 163
Substance abuse and schizophrenia: Pharmacotherapeutic intervention
Green, A. I., Noordsy, D. L., Brunette, M. F., & O’Keefe, C. D. (2007) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.01.008 · Cited by 157
Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity.
Gut-Fayand, A., Dervaux, A., Olié, J., Lôo, H., Poirier, M., & Krebs, M. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00250-5 · Cited by 169
Swartz, M. S., Wagner, H. R., Swanson, J. W., Stroup, T. S., McEvoy, J. P., Canive, J. M., Miller, D. D., Reimherr, F., McGee, M., Khan, A., et al. (2006) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000202575.79453.6e · Cited by 146
Carey, M. P., Carey, K. B., Maisto, S. A., Gordon, C. M., Schröder, K. E. E., & Vanable, P. A. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.2.252 · Cited by 145
Is Cannabis Use a Contributory Cause of Psychosis?
Degenhardt, L. J., & Hall, W. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100903 · Cited by 134
Novel Psychoactive Substances in Young Adults with and without Psychiatric Comorbidities
Martinotti, G., Lupi, M., Acciavatti, T., Cinosi, E., Santacroce, R., Signorelli, M. S., Bandini, L., Lisi, G., Quattrone, D., Ciambrone, P., et al. (2014) · BioMed Research International · doi:10.1155/2014/815424 · Cited by 120
Thoma, P., & Daum, I. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12072 · Cited by 107
Bolton, C. A., Gooding, P. A., Kapur, N., Barrowclough, C., & Tarrier, N. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.12.001 · Cited by 113
Cannabis use and psychotic disorders: an update
Hall, W., Degenhardt, L. J., & Teesson, M. (2004) · Drug and Alcohol Review · doi:10.1080/09595230412331324554 · Cited by 107
Sevy, S. M., Robinson, D. G., Napolitano, B. A., Patel, R. C., Gunduz‐Bruce, H., Miller, R., McCormack, J., Lorell, B. S., & Kane, J. M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.03.037 · Cited by 90
Comorbid mental disorders and substance use disorders: epidemiology, prevention and treatment
Proudfoot, M. T. H. (2004) · Cited by 88
The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia
Krystal, J. H., D’Souza, D. C., Gallinat, J., Driesen, N. R., Abi‐Dargham, A., Petrakis, I. L., Heinz, A., & Pearlson, G. D. (2006) · Neurotoxicity Research · doi:10.1007/bf03033360 · Cited by 87
Schizophrenia and Other Psychotic Disorders
Gregg, L. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3375-0_25 · Cited by 77
Patterns and Predictors of Substance use Disorders and Daily Tobacco use in First-Episode Psychosis
Wade, D., Harrigan, S., Edwards, J., Burgess, P., Whelan, G., & McGorry, P. (2005) · Australian and New Zealand journal of psychiatry (Print) · doi:10.1080/j.1440-1614.2005.01699.x · Cited by 67
Moore, E., Mancuso, S. G., Slade, T. N., Galletly, C. A., & Castle, D. J. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412443900 · Cited by 69
Swartz, M. S., Wagner, H. R., Swanson, J. W., Stroup, T. S., McEvoy, J. P., McGee, M., Miller, D. D., Reimherr, F. W., Khan, A., Cañive, J. M., et al. (2006) · Psychiatric Services · doi:10.1176/ps.2006.57.8.1110 · Cited by 67
Degenhardt, L. J., & Hall, W. (2002) · Current Psychiatry Reports · doi:10.1007/s11920-002-0026-5 · Cited by 68
Swartz, J. A., & Lurigio, A. J. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.04.009 · Cited by 66
Dekker, N. L., Linszen, D. H., & de Haan, L. (2009) · Psychopathology · doi:10.1159/000236906 · Cited by 65
Why do patients with psychosis use cannabis and are they ready to change their use?
Kolliakou, A., Joseph, C., Ismail, K., Atakan, Z., & Murray, R. M. (2010) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.11.006 · Cited by 65
Swartz, M. S., Wagner, H. R., Swanson, J. W., Stroup, T. S., McEvoy, J. P., Reimherr, F. W., Miller, D. D., McGee, M., Khan, A., Cañive, J. M., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.034 · Cited by 63
Cannabis use and cognitive functioning in first-episode schizophrenia patients
Rodríguez-Sánchez, J. M., Ayesa‐Arriola, R., Mata, I. F., Moreno-Calle, T., Pérez‐Iglesias, R., González‐Blanch, C., Periañez, J. A., Vázquez‐Barquero, J. L., & Crespo‐Facorro, B. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.08.017 · Cited by 61
The Feasibility of Enhancing Psychiatric Outpatients' Readiness to Change Their Substance Use
Carey, K. B., Carey, M. P., Maisto, S. A., & Purnine, D. M. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.5.602 · Cited by 58
Potvin, S., Stip, E., & Roy, J. (2003) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000063501.97247.38 · Cited by 69
O’Hare, T., & Sherrer, M. V. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.01.006 · Cited by 59
Costs of psychosis in 2010: Findings from the second Australian National Survey of Psychosis
Neil, A. L., Carr, V. J., Mihalopoulos, C., Mackinnon, A. J., & Morgan, V. A. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413500352 · Cited by 56
Eack, S. M., Hogarty, S. S., Greenwald, D. P., Litschge, M. Y., McKnight, S. A. F., Bangalore, S. S., Pogue‐Geile, M. F., Keshavan, M. S., & Cornelius, J. R. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.11.017 · Cited by 56
Korotkova, E. I., Misini, B., Дорожко, Е. В., Bukkel, M. V., Plotnikov, E. V., & Linert, W. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12010401 · Cited by 52
Barrowclough, C., Haddock, G., Beardmore, R., Conrod, P., Craig, T., Davies, L., Dunn, G., Lewis, S., Moring, J., Tarrier, N., et al. (2009) · Addictive Behaviors · doi:10.1016/j.addbeh.2009.03.007 · Cited by 51
Zhornitsky, S., Rizkallah, É., Pampoulova, T., Chiasson, J., Lipp, O., Stip, É., & Potvin, S. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.07.046 · Cited by 51
Substance abuse amplifies the risk for violence in schizophrenia spectrum disorder
Erkıran, M., Özünalan, H., Evren, C., Aytaçlar, S., Kirisci, L., & Tarter, R. E. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.12.024 · Cited by 51
Meta-Analysis of Depressive Symptoms in Dual-Diagnosis Schizophrenia
Potvin, S., Sepehry, A. A., & Stip, É. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670701579041 · Cited by 51
Functional analysis of schizophrenia genes using GeneAnalytics program and integrated databases
Sundararajan, T., Manzardo, A. M., & Butler, M. G. (2017) · Gene · doi:10.1016/j.gene.2017.10.035 · Cited by 53
Cultural Mistrust and the Clinical Diagnosis of Paranoid Schizophrenia in African American Patients
Whaley, A. L. (2001) · Journal of Psychopathology and Behavioral Assessment · doi:10.1023/a:1010911608102 · Cited by 50
Rosenfarb, I. S., Bellack, A. S., & Aziz, N. (2006) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.115.1.157 · Cited by 53
Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
Amato, D., Kruyer, A., Samaha, A., & Heinz, A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00314 · Cited by 47
Tandberg, M., Ueland, T., Sundet, K. S., Haahr, U., Joa, I., Johannessen, J. O., Larsen, T. K., Opjordsmoen, S., Rund, B. R., Røssberg, J. I., et al. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.04.021 · Cited by 46
Comorbid conditions in schizophrenia
Fenton, W. S. (2001) · Current Opinion in Psychiatry · doi:10.1097/00001504-200101000-00004 · Cited by 46
Marijuana Use and Depressive Symptoms; Gender Differences in African American Adolescents
Assari, S., Mistry, R., Caldwell, C. H., & Zimmerman, M. A. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.02135 · Cited by 48
Enhanced methamphetamine self-administration in a neurodevelopmental rat model of schizophrenia
Brady, A. M., McCallum, S. E., Glick, S. D., & O’Donnell, P. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1195-7 · Cited by 43
Normal Personality Characteristics in Schizophrenia: A Review of the Literature Involving the FFM
Dinzeo, T. J., & Docherty, N. M. (2007) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000253795.69089.ec · Cited by 43
Walking the fine line: Self-reported reasons for substance use in persons with severe mental illness
Pettersen, H., Ruud, T., Ravndal, E., & Landheim, A. (2013) · International Journal of Qualitative Studies on Health & Well-Being · doi:10.3402/qhw.v8i0.21968 · Cited by 42
Marquez-Arrico, J. E., Benaiges, I., & Adán, A. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.028 · Cited by 40
Morrens, M., Dewilde, B., Sabbe, B., Dom, G., Cuyper, R. D., & Moggi, F. (2011) · European Addiction Research · doi:10.1159/000324480 · Cited by 40
Treatment development for psychosis and co-occurring substance misuse: A descriptive review
Barrowclough, C., Haddock, G., Fitzsimmons, M., & Johnson, R. (2006) · Journal of Mental Health · doi:10.1080/09638230600998920 · Cited by 40
Gender differences in the association between environment and psychosis
Yay-Pence, A., Pries, L.-K., Ferrara, M., Rutten, B. P. F., van Os, J., & Gülöksüz, S. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.02.039 · Cited by 43
Treatment of substance use disorders in schizophrenia: A unifying neurobiological mechanism?
Roth, R. M., Brunette, M. F., & Green, A. I. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0082-8 · Cited by 38
Lukasiewicz, M., Blecha, L., Falissard, B., Neveu, X., Benyamina, A., Reynaud, M., & Gasquet, I. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00819.x · Cited by 38
Repetto, P. B., Zimmerman, M. A., & Caldwell, C. H. (2008) · Journal of Research on Adolescence · doi:10.1111/j.1532-7795.2008.00566.x · Cited by 39
Doppeldiagnose Psychose und Sucht
Gouzoulis‐Mayfrank, E. (2004) · Der Nervenarzt · doi:10.1007/s00115-004-1692-9 · Cited by 35
Pennou, A., Lecomte, T., Potvin, S., & Khazaal, Y. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00302 · Cited by 34
Co-morbid PTSD and suicidality in individuals with schizophrenia and substance and alcohol abuse
Tarrier, N., & Picken, A. (2011) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-010-0277-0 · Cited by 33
Heslop, K., Ross, C., Osmond, B., & Wynaden, D. (2013) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-013-9428-3 · Cited by 33
Substance abuse and quality of life among severely mentally ill consumers
Urbanoski, K. A., Cairney, J., Adlaf, E. M., & Rush, B. R. (2007) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-007-0236-6 · Cited by 33
The link between cannabis use and psychosis: furthering the debate
Degenhardt, L. J. (2002) · Psychological Medicine · doi:10.1017/s0033291702007080 · Cited by 33
Müller, C. P., Schumann, G., Rehm, J. T., Kornhuber, J., & Lenz, B. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02074-3 · Cited by 34
Diagnostic Comorbidity in Psychotic Offenders and Their Criminal History: A Review of the Literature
Goethals, K., Vorstenbosch, E., & Marle, H. J. C. V. (2008) · International Journal of Forensic Mental Health · doi:10.1080/14999013.2008.9914411 · Cited by 31
Race, Family Interactions, and Patient Stabilization in Schizophrenia.
Rosenfarb, I. S., Bellack, A. S., Aziz, N., Kratz, K. M., & Sayers, S. L. (2004) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.113.1.109 · Cited by 32
Predictors of Alcohol and Drug Dependence
Fleury, M., Grenier, G., Bamvita, J., Perreault, M., & Caron, J. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900405 · Cited by 31
Management of Schizophrenia with Substance Use Disorders
Lybrand, J., & Caroff, S. N. (2009) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.09.002 · Cited by 31
Picken, A., & Tarrier, N. (2010) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2010.10.008 · Cited by 29
Mancini-Marı̈e, A., Potvin, S., Fahim, C., Beauregard, M., Mensour, B., & Stip, É. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0302 · Cited by 28
Substance Use in Patients With First-Episode Psychosis: Is Gender Relevant?
Arranz, B., Safont, G., Corripio, I., Ramirez, N., Dueñas, R., Pérez, V., Álvarez, E., & San, L. (2015) · Journal of Dual Diagnosis · doi:10.1080/15504263.2015.1113761 · Cited by 27
Costs of schizophrenia during 5 years
Lindström, E., Eberhard, J., Neovius, M., & Levander, S. E. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01086.x · Cited by 27
Paranoia in African-American men receiving inpatient psychiatric treatment.
Whaley, A. L. (2004) · PubMed · Cited by 27
Impulsivity and risk-taking in co-occurring psychotic disorders and substance abuse
Marcello, S. C., Silverstein, S. M., & Spiga, R. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.08.014 · Cited by 26
Gonzalez, V. M., Bradizza, C. M., Vincent, P. C., Stasiewicz, P. R., & Paas, N. D. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2006.05.012 · Cited by 26
Tantirangsee, N., Assanangkornchai, S., & Marsden, J. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.10.011 · Cited by 25
Desmarais, S. L., Dorn, R. A. V., Sellers, B. G., Young, M. S., & Swartz, M. S. (2012) · Psychology of Addictive Behaviors · doi:10.1037/a0031256 · Cited by 27
Amphetamines for schizophrenia
Nolte, S., Wong, D., Latchford, G. J., Boyle, O., & Anaenugwu, A. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004964 · Cited by 25
Borçoi, A. R., Patti, C. L., Zanin, K. A., Hollais, A. W., Santos-Baldaia, R., Ceccon, L. M. B., Berro, L. F., Wuo‐Silva, R., Grapiglia, S. B., Ribeiro, L. T. C., et al. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.05.015 · Cited by 24
James, A. V., Leonhardt, B. L., & Buck, K. D. (2018) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.20180038 · Cited by 24
Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders
Akerman, S. C., Brunette, M. F., Noordsy, D. L., & Green, A. I. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0034-7 · Cited by 23
Prevalence of Substance Use in Patients Diagnosed with Schizophrenia
Uludağ, Y. T., & Gulenc, G. (2015) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2015.8827 · Cited by 23
Homelessness and Mental Disorders
Martens, W. H. J. (2001) · International Journal of Mental Health · doi:10.1080/00207411.2001.11449534 · Cited by 23
Pharmacological Treatment of Schizophrenia and Co-Occurring Substance Use Disorders
Smelson, D. A., Dixon, L. B., Craig, T., Remolina, S., Batki, S. L., Niv, N., & Owen, R. R. (2008) · CNS Drugs · doi:10.2165/00023210-200822110-00002 · Cited by 22
Bourque, J., Mendrek, A., Durand, M., Lakis, N., Lipp, O., Stip, É., Lalonde, P., Grignon, S., & Potvin, S. (2013) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2013.05.012 · Cited by 21
Conrad, A. M., Lewin, T. J., Sly, K. A., Schall, U., Halpin, S. A., Hunter, M., & Carr, V. J. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0318-4 · Cited by 21
Saddichha, S., Sur, S., Sinha, B. N. P., & Khess, C. R. J. (2010) · Substance Abuse · doi:10.1080/08897070903442699 · Cited by 22
Suicidal Behavior in the Older Patient with Schizophrenia
Kasckow, J., Montross, L. P., Prunty, L., Fox, L. J., & Zisook, S. (2011) · Aging Health · doi:10.2217/ahe.11.23 · Cited by 21
Metadata
- Authors
- Blanchard, J.
- Affiliations
- University of New Mexico (US)
- Corresponding author
- Blanchard, J
- ORCID
- Blanchard, J
- Venue
- Clinical Psychology Review
- Publisher
- Elsevier BV
- Published
- 2000-03
- Volume
- 20
- Issue
- 2
- Pages
- 207-234
- ISSN
- 0272-7358 (ISSN-L)
- OpenAlex
- W2040936438
- Cited by
- 240
- References
- 169
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 3 · 2023: 4 · 2022: 9 · 2021: 4 · 2020: 4 · 2019: 12 · 2018: 7 · 2017: 8 · 2016: 9 · 2015: 10 · 2014: 15 · 2013: 15 · 2012: 11
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Psychology Review (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH51240)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- substance use disorders, schizophrenia, comorbidities, self-medication, stress response, individual differences, genetic relatedness, prevalence, adverse outcomes, suicide, homelessness, incarceration
- MeSH terms
- Affect, Emotions, Humans, Models, Psychological, Schizophrenia, Comorbidity, Diagnosis, Dual (Psychiatry), Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review